- US12186392utility2025Combination Therapy of an Anti CD20 Antibody with a BTK Inhibitor0 cites
- US12179948utility2024Time-pressure-filling System for Liquid Drug Products0 cites
- US12180279utility2024Method for in Vivo Generation of Multispecific Antibodies from Monospecific Antibodies0 cites
- US12172982utility2024Synthesis of Quinazoline Compounds0 cites
- US12174184utility2024Target Interference Suppressed Anti-drug Antibody Assay0 cites
- US12162887utility2024Spiro-oxazolones0 cites
- US12163131utility2024Oligonucleotides for Modulating Tau Expression0 cites
- US12157746utility2024Tetrahydro-1h-pyrazino[2,1-a]isoindolylquinoline Compounds for the Treatment of Autoimmune Disease0 cites
- US12157770utility2024Anti-hla-g Antibodies and Methods of Use Thereof0 cites
- US12145940utility2024Ethynyl Derivatives0 cites
- US12145994utility2024Bispecific Antigen Binding Molecules Capable of Specific Binding to CD40 and to Fap0 cites
- US12139506utility2024Process for the Preparation of Galnac Phosphoramidite Epimers0 cites
- US12139553utility2024T Cell Activating Bispecific Antigen Binding Molecules0 cites
- US12133963utility2024Syringe Pack and Method of Packing a Prefilled Syringe0 cites
- US12134599utility2024Solid Forms0 cites
- US12128103utility2024Adjuvant Treatment of Her2-positive Breast Cancer0 cites
- US12122789utility2024Forms of Pyrido[1,2-a]pyrimidin-4-one Derivatives, Its Formulation and Its Process of Making0 cites
- US12116349utility2024Methylquinazolinone Derivatives0 cites
- US12116576utility2024Oligonucleotides for Modulating SCN9A Expression0 cites